Articles

Cohort study aims to determine whether or not these regulatory changes in state government have helped reverse opioid mortality rates. 

The Association Between Cannabis Legalization and Opioid Overdoses

In an interview with Pharma Commerce Associate Editor Don Tracy, Ron Lanton, Partner, Lanton Law PLLC, discusses recent moves by CVS and Express Scripts to follow Mark Cuban's drug plus model.

Ron Lanton, Partner, Lanton Law PLLC, Discusses New Drug Plus Pricing Models

KEYNOTE-564 is the first Phase III adjuvant trial to show improved survival for renal cancer patients at risk of recurrence after surgery following treatment with Keytruda.

Keytruda Shows 38% Improved Survival in Renal Cell Carcinoma Patients

Trial data show Enhertu produced clinically meaningful and durable responses for a survival benefit in patients previously administered treatment for HER2-expressing metastatic solid tumors.

 Enhertu Earns FDA Priority Review for HER2-Positive Solid Tumors

One lot of the company’s branded dextroamphetamine sulfate tablets is being removed from shelves nationwide due to a pharmacy receiving carbinoxamine maleate instead. 

Azurity Pharmaceuticals Recalls Zenzedi

A non-randomized control trial investigates whether older adults with multiple chronic conditions can benefit by receiving more specialized services.

Does Patient Priorities Care Result in Better Outcomes for Patients?

GLP-1 agonists may be an effective therapy to avoid severe liver disease in those with concurrent type 2 diabetes.

GLP-1 Agonists Could Be Key in Reducing Severe Liver Disease for Type 2 Diabetes Patients

Michael Christel is Group Managing Editor of Pharmaceutical Commerce, Pharmaceutical Executive, and Applied Clinical Trials. He can be reached at mchristel@mjhlifesciences.com.

A deep dive into the complex playing field for M&A and partnering pursuits in today’s increasingly make-or-break landscape for biopharma innovation. 

The Twists and Turns in Biopharma Dealmaking: 2024 Trends

As providers and healthcare professionals recognize the potential of long-acting injectables to fight the opioid epidemic, many are actively transitioning from oral options to injectables.

Breaking the Chains of Opioid Addiction: The Promise of Long-Acting Injectables 

The Identification of Medicinal Product framework seeks to establish a common language for identifying, documenting, and exchanging information about medicinal products.

News